kidney disease
Renalytix, Partners Launch $10M Consortium to Develop Kidney Disease Drug Response Tests
Renalytix said it will receive about $1 million in consortium funding to oversee commercial translation activities around the tests.
Renalytix Posts $2.9M in Revenue for Fiscal 2022
The kidney disease-focused in vitro diagnostics firm nearly doubled the previous year's revenue and posted a net loss of $45.3 million in the year ending June 30.
Kidney Disease Targets Uncovered in Integrated Omics Analysis
Using genetic, epigenetic, expression, and other data, researchers narrowed in on genes, pathways, and cell types involved in kidney disease.
The study looked at Black patients with the APOL1 genotype, a signifier of increased risk of kidney failure.
RenalytixAI, Wake Forest, Atrium Health Partner on Kidney Health Initiative
RenalytixAI will offer its KidneyIntelX platform through Atrium Health's electronic health record system at 37 hospitals across the Carolinas and Georgia.